CIBC Private Wealth Group
BDSX icon

CIBC Private Wealth Group’s Biodesix BDSX Stock Holding History

CIBC Private Wealth Group’s Portfolio BDSX Stock Details BDSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,466
Closed -$11.1K – 3404
2025
Q3 		$11.1K Sell
1,466
-1
-0.1% -$8 ﹤0.01% 2351
2025
Q2 		$8.28K Hold
1,467
– – ﹤0.01% 2324
2025
Q1 		$17.2K Hold
1,467
– – ﹤0.01% 2055
2024
Q4 		$43.4K Hold
1,467
– – ﹤0.01% 1724
2024
Q3 		$52.2K Hold
1,467
– – ﹤0.01% 1758
2024
Q2 		$46.6K Buy
1,467
+812
+124% +$23.2K ﹤0.01% 1706
2024
Q1 		$19.3K Hold
655
– – ﹤0.01% 2062
2023
Q4 		$24.1K Hold
655
– – ﹤0.01% 1120
2023
Q3 		$21.6K Hold
655
– – ﹤0.01% 1061
2023
Q2 		$16.1K Hold
655
– – ﹤0.01% 871
2023
Q1 		$24.4K Hold
655
– – ﹤0.01% 877
2022
Q4 		$30 Buy
+655
New +$17.8K ﹤0.01% 844

Other funds holding BDSX

TAM
Telemark Asset Management Boston, Massachusetts $1.08B AUM 70.88% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MIM
Monashee Investment Management Boston, Massachusetts $184M AUM 197.43% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

CIBC Private Wealth Group's BDSX Position: Q4 2025 in Review

CIBC Private Wealth Group sold out of Biodesix (BDSX) in Q4 2025, closing a stake of 1,466 shares — an estimated $11.1K sold.

CIBC Private Wealth Group first reported a position in BDSX in Q4 2022 and held it in 12 quarters. The position peaked at $52.2K in Q3 2024. 26 funds tracked by Wall St. Rank hold BDSX as of Q4 2025.

  • CIBC Private Wealth Group reported no remaining Biodesix position as of Q4 2025 after selling out during the quarter.
  • CIBC Private Wealth Group sold 1,466 Biodesix shares in Q4 2025, an estimated $11.1K.
  • CIBC Private Wealth Group first reported a position in Biodesix in Q4 2022 and held it in 12 quarters.
  • CIBC Private Wealth Group's Biodesix position peaked at $52.2K in Q3 2024.
  • 26 funds tracked by Wall St. Rank held Biodesix as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.